This article released 12-05-2016.
Not sure if I missed the announcement of such but I'm sure one of the things they had on their list of achievements for this year was to publish a few articles in reputable medical journals. Not sure if this qualifies.
Also not sure why they don't share this info with the general market.
NEWS AND NOTES Analytica Publishes Two Cases On Effectivenes of PeriCoach® Pelvic Floor Trainer
Denver, CO, April 25, 2016 -- Analytica announced today the findings of two Case Reports describing pelvic floor training with PeriCoach published in the Urologic Nursing Journal of the Society of Urological Nursing Association. These cases demonstrate the efficacy and ease of use of PeriCoach in the treatment of common pelvic floor dysfunctions, such as urinary incontinence, as well as the emotional and lifestyle benefits of restoring pelvic floor strength.
The Case reported by Julie Starr, APRN, FNP, Women's Health Care, University of Missouri Healthcare, describes the experience of an athletic 37-year-old woman seeking treatment for symptoms of stress urinary incontinence.
The Case reported by Beth Shelley, PT, DPT, WCS, BCB-PMD,describes the experience of a 66-year-old woman with Pelvic Organ Prolapse (POP) and urinary incontinence who performed at-home PFME with the assistance of PeriCoach.
In both Cases, PeriCoach was demonstrated to be an easy-to-use, affordable and effective non-surgical home training option for strengthening pelvic floor muscles and decreasing symptoms of UI and POP.
PeriCoach is a novel, at-home pelvic floor muscle trainer featuring a vaginal sensor and a smartphone app. PeriCoach takes the guesswork out of pelvic floor muscle exercises to help women strengthen and tone their pelvic floors with confidence.
One in three women will experience UI at some point in their lives.
Clinical experiences with PeriCoach have been published and accepted for presentation in other peer-reviewed publications and conferences.
PeriCoach has regulatory clearance in Australia and has CE mark and USFDA 510(k) clearance. The product is available for sale in Australia, New Zealand, UK and Ireland, and in the US by prescription.